AYA Artrya pops +11% on yet another FDA approval for an Aussie biotech Artrya (ASX:AYA) is the latest Aussie biotech stock to see an FDA approval and consequent rewarding share price jump from traders and investors. Jonathon Davidson 28 Mar 2025 11:50 (AEDT) ASX News Healthcare Medical Care
COV CLEO Diagnostics kicks off IP transfer for ovarian cancer blood tests to US manufacturers CLEO Diagnostics has commenced the 'technology transfer' process to a US-based manufacturing partner ahead of commercialisation. Jonathon Davidson 18 Mar 2025 12:24 (AEDT) ASX News Healthcare Medical Care
